The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[(4-Chloro-2-cyclohexylsulfanyl-5-sulfamoylbenzoyl)amino]butanoic acid ID: ALA4513684
PubChem CID: 126508867
Max Phase: Preclinical
Molecular Formula: C17H23ClN2O5S2
Molecular Weight: 434.97
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)c1cc(C(=O)NCCCC(=O)O)c(SC2CCCCC2)cc1Cl
Standard InChI: InChI=1S/C17H23ClN2O5S2/c18-13-10-14(26-11-5-2-1-3-6-11)12(9-15(13)27(19,24)25)17(23)20-8-4-7-16(21)22/h9-11H,1-8H2,(H,20,23)(H,21,22)(H2,19,24,25)
Standard InChI Key: QBFWPSYDISFIKC-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
15.5912 -23.4853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2998 -23.8906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3027 -24.7132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5930 -25.1227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8850 -24.7137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8861 -23.8942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1769 -25.1217 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.5928 -25.9399 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.8850 -26.3483 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0021 -26.6488 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4107 -25.9399 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.0060 -23.4793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7152 -23.8852 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0029 -22.6621 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4214 -23.4740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1306 -23.8799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8368 -23.4686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5461 -23.8746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2522 -23.4633 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.5491 -24.6917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5888 -22.6681 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.8798 -22.2616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8814 -21.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1733 -21.0404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4658 -21.4512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4709 -22.2726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1795 -22.6753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
5 7 1 0
4 8 1 0
8 9 1 0
8 10 2 0
8 11 2 0
2 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
18 20 1 0
1 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 434.97Molecular Weight (Monoisotopic): 434.0737AlogP: 3.01#Rotatable Bonds: 8Polar Surface Area: 126.56Molecular Species: ACIDHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.07CX Basic pKa: ┄CX LogP: 2.48CX LogD: -1.00Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.54Np Likeness Score: -1.27
References 1. Zakšauskas A, Čapkauskaitė E, Jezepčikas L, Linkuvienė V, Paketurytė V, Smirnov A, Leitans J, Kazaks A, Dvinskis E, Manakova E, Gražulis S, Tars K, Matulis D.. (2020) Halogenated and di-substituted benzenesulfonamides as selective inhibitors of carbonic anhydrase isoforms., 185 [PMID:31740053 ] [10.1016/j.ejmech.2019.111825 ]